Agenus to Present Clinical Data on Lead Programs at ASCO 2018

Author's Avatar
May 17, 2018
Article's Main Image

- AGEN1884 (CTLA-4) and AGEN2034 (PD-1) show objective clinical responses

- More than 100 patients treated with AGEN1884 and AGEN2034

- Combination trial has commenced in cervical cancer

PR Newswire